South Korea · Delayed Price · Currency is KRW Kyung Nam Pharm Statistics
Total Valuation
Kyung Nam Pharm has a market cap or net worth of KRW 43.26 billion. The enterprise value is 44.03 billion.
| Market Cap | 43.26B |
| Enterprise Value | 44.03B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kyung Nam Pharm has 19.62 million shares outstanding.
| Current Share Class | 19.62M |
| Shares Outstanding | 19.62M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.48 |
| P/OCF Ratio | 6.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.17, with an EV/FCF ratio of 26.96.
| EV / Earnings | n/a |
| EV / Sales | 0.78 |
| EV / EBITDA | 16.17 |
| EV / EBIT | 66.19 |
| EV / FCF | 26.96 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -0.23% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.37% |
| Revenue Per Employee | 225.89M |
| Profits Per Employee | -21.08M |
| Employee Count | 243 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Kyung Nam Pharm has paid 483.98 million in taxes.
| Income Tax | 483.98M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.29% in the last 52 weeks. The beta is 0.20, so Kyung Nam Pharm's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -28.29% |
| 50-Day Moving Average | 1,670.64 |
| 200-Day Moving Average | 2,873.27 |
| Relative Strength Index (RSI) | 63.71 |
| Average Volume (20 Days) | 804,084 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kyung Nam Pharm had revenue of KRW 54.89 billion and -5.12 billion in losses. Loss per share was -575.49.
| Revenue | 54.89B |
| Gross Profit | 15.32B |
| Operating Income | 952.96M |
| Pretax Income | -1.57B |
| Net Income | -5.12B |
| EBITDA | 1.27B |
| EBIT | 952.96M |
| Loss Per Share | -575.49 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 6.54 billion and capital expenditures -4.91 billion, giving a free cash flow of 1.63 billion.
| Operating Cash Flow | 6.54B |
| Capital Expenditures | -4.91B |
| Depreciation & Amortization | 313.62M |
| Net Borrowing | -576.33M |
| Free Cash Flow | 1.63B |
| FCF Per Share | 83.26 |
Margins
Gross margin is 27.91%, with operating and profit margins of 1.74% and -9.33%.
| Gross Margin | 27.91% |
| Operating Margin | 1.74% |
| Pretax Margin | -2.85% |
| Profit Margin | -9.33% |
| EBITDA Margin | 2.31% |
| EBIT Margin | 1.74% |
| FCF Margin | 2.98% |
Dividends & Yields
Kyung Nam Pharm does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.37% |
| Shareholder Yield | -25.37% |
| Earnings Yield | -11.84% |
| FCF Yield | 3.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 14, 2026. It was a reverse split with a ratio of 0.2.
| Last Split Date | Apr 14, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |